Effect of nasal corticosteroids on pathophysiology of bronchial asthma

Effect of nasal corticosteroids on pathophysiology of bronchial asthma - Nasal corticosteroids and asthma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007301

Enrollment

100

Registered

2012-02-20

Start date

2012-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bronchial asthma allergic rhinitis

Interventions

Nasal corticosteroids

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Asthma Allergic rhinitis

Exclusion criteria

Exclusion criteria: 1, Diagnosed with non-asthma respiratory disorders 2, Poor adherence 3, Use nasal corticosteroids within 8 weeks before enrollment 4, The patients who are inappropriate considered by physician

Design outcomes

Primary

Measure	Time frame
Asthma control questionnaire lung function test exhaled nitric oxide	—

Countries

Japan

Contacts

Public ContactKazuto Matsunaga

Wakayama Medical University Third Department of Internal Medicine

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026